Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting ...
During the resumed hearing on April 17, the scheduled cross-examination of the whistleblower and prime witness was deferred ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that safety and tolerability data from the ProstACT Global Phase 3 study (Part 1) will be presented as a late-breaking ...
An examination of how a practice rooted in 19th-century psychiatric theory survived clinical repudiation, evolved through religious institutions, and became the subject of sweeping legislative action ...
Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.
Updated guidance on pain control for cattle of all ages is among changes proposed in the updated draft beef code of practice ...
Farmers have raised concerns about the potential impact of proposed changes to lamb tail docking following a UK-wide ...
In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key ...
Clinical Trials Arena on MSN
Acerand reports first-in-human trial results for ACE-106 therapy
ACE-106 demonstrated notable anti-tumour activity across different tumour types.
On Sunday, a community centre in Montreal hosted a Palestinian prisoners speaking event that celebrated convicted terrorists ...
Bayer failed to persuade a federal judge to grant a preliminary injunction in its lawsuit accusing drugmaker Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results